M4MM
The Garden Returns: Spiritual Plants Launches a New Category of Plant Medicine Rooted in Ritual, Not Recreation
LOS ANGELES, CA — Spiritual Plants today announced its formal market entry as a belief-driven plant medicine platform built around ritual, intention, and repeatable practice—not recreational hype or potency escalation. Founded by cultural strategist and ...
Cronos Introduces Premium Brand to Israeli Medical Cannabis Market
TORONTO – Cronos Group Inc. has launched its premium Cannabis brand in Israel, making five indoor-grown strains available to medical patients through pharmacies across the country. The announcement represents the latest step in Cronos' strategy ...
Washington Senate Committee Advances Home Cannabis Cultivation Bill
WASHINGTON – The Washington State Senate Labor & Commerce Committee has approved Senate Bill 6204, advancing legislation that would permit adults 21-plus to grow limited amounts of Cannabis at home for personal use. Introduced in ...
Psychedelic Pharmacists Foundation Launches to Advance Education and Research
PORTLAND – The Psychedelic Pharmacists Association (PPA) has launched the Psychedelic Pharmacists Foundation (PPF), a new nonprofit entity focused on education, research, and public awareness of responsible psychedelic medicine integration. The PPF will operate as ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The Cannabis and Psychedelics worlds delivered a fresh wave of momentum that’s turning heads from boardrooms to ballot boxes. States pushed bold new frontiers in therapeutic access, millions of Americans embraced microdosing ...
DOJ Keeps Silent on Cannabis Rescheduling Updates
WASHINGTON – It's been more than 40 days since President Donald Trump signed an executive order calling for the swift rescheduling of Cannabis, yet the Department of Justice (DOJ) remains tight-lipped on any progress. A ...
High Tide Reports Q4 and Full FY 2025 Financial Results
CALGARY – High Tide Inc., the Canadian Cannabis retailer operating the Canna Cabana dispensary chain, released its audited financial results for the fourth quarter and full fiscal year ended October 31, 2025, reporting record revenue ...
The Garden Returns: Spiritual Plants Launches a New Category of Plant Medicine Rooted in Ritual, Not Recreation
LOS ANGELES, CA — Spiritual Plants today announced its formal market entry as a belief-driven plant medicine platform built around ritual, intention, and repeatable practice—not recreational hype or potency escalation. Founded by cultural strategist and ...
Cronos Introduces Premium Brand to Israeli Medical Cannabis Market
TORONTO – Cronos Group Inc. has launched its premium Cannabis brand in Israel, making five indoor-grown strains available to medical patients through pharmacies across the country. The announcement represents the latest step in Cronos' strategy ...
Washington Senate Committee Advances Home Cannabis Cultivation Bill
WASHINGTON – The Washington State Senate Labor & Commerce Committee has approved Senate Bill 6204, advancing legislation that would permit adults 21-plus to grow limited amounts of Cannabis at home for personal use. Introduced in ...
Grown Rogue Claims Ground in Minnesota
MINNEAPOLIS – Grown Rogue International Inc., a Сannabis MSO focused on premium flower, has signed a long-term lease for a 109,000-square-foot facility in Fridley, just north of Minneapolis, positioning the company to produce for the ...
New Mexico Speeds Up Psilocybin Therapy Access
SANTA FE – State health leaders in New Mexico outlined plans this week to open a regulated psilocybin therapy program by the close of 2026, advancing the timeline a full year from the original statutory ...
Stiiizy Expands California Retail Network Buying 12 Gold Flora Outlets
LOS ANGELES – Stiiizy, the dominant player in California's Cannabis retail, has taken control of 12 former Gold Flora dispensaries in a $25 million court-approved transaction, marking a key step in the state's ongoing industry ...
Cronos Targets Europe Through Dutch Cannabis Leader Acquisition
TORONTO – Cronos Group Inc. has agreed to buy CanAdelaar B.V., the top supplier in the Netherlands' controlled adult-use Cannabis program, for $67 million upfront plus performance incentives. The move marks Cronos's first major step ...
Craft Cannabis Market Projects Steady Climb to $12.3B by 2031
LOS ANGELES – Small-scale producers in the Cannabis industry are gaining ground as buyers turn toward premium, handcrafted options, with the craft segment expected to double in value over the next five years. A report ...
FDA Signals Shift to Single Phase 3 Trials for Drug Approvals, Opening Door for Faster Psychedelic Therapies
LOS ANGELES – The Food and Drug Administration is preparing to overhaul its evidence requirements for new drug approvals, making a single well-designed Phase 3 trial the standard rather than the exception. This adjustment, outlined ...
Trulieve Clears $368M Debt with Full Redemption of Senior Notes
TALLAHASSEE – Trulieve Cannabis Corp. wrapped up the buyback of its entire $368 million stack of 8% senior secured notes set to mature in 2026, handing over about $373 million in cash to cover the ...
OPINION: MJBizCon25 Review: The Race To Be Second
LAS VEGAS- Gosh… the MJBizCon I attended was awesome — genuinely one of the best and most productive ones I’ve ever been to — which is why I was so surprised to see how much ...
CRS Reveals Hemp Ban Enforcement Hurdles
WASHINGTON – The Congressional Research Service (CRS) has highlighted gaps in the federal government's plans to enforce the upcoming ban on intoxicating hemp products, raising questions about the practical reach of the law amid the ...
Federal Hemp Overhaul Threatens Cannabis Seed Trade, Sparking Breeder Backlash
LOS ANGELES – A tucked-away clause in last month's federal spending package has upended the rules for Cannabis seeds, thrusting the U.S. genetics sector into uncertainty and prompting warnings from cultivators that prized strains could ...
CMI Projects Double-Digit Expansion for Cannabis Testing Market
LOS ANGELES – A recent analysis from Custom Market Insights (CMI) forecasts the global Cannabis testing market to climb from $2.13 billion in 2025 to $11.15 billion by 2034, powered by a CAGR of 18%. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered a surge of momentum across the U.S. Cannabis and Psychedelics sectors, where federal signals on coverage and equity met bold state actions on access and licensing. Operators navigated ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
RESPECT: House Lawmakers Introduce Cannabis Equity Resolution
WASHINGTON – A group of eight House lawmakers, led by members of the Congressional Cannabis Caucus, filed a resolution aimed at bolstering fair access to the burgeoning Cannabis sector for communities long sidelined by federal ...
Bipartisan Measure Targets Barriers to Psychedelic Therapies for Terminal Patients
WASHINGTON – A group of House and Senate lawmakers from both parties unveiled legislation to permit physicians to deliver Schedule I substances, including MDMA and psilocybin, to individuals grappling with terminal illnesses or severe mental ...
